177 related articles for article (PubMed ID: 18418892)
1. Differential effect of ascorbic acid and n-acetyl-L-cysteine on arsenic trioxide-mediated oxidative stress in human leukemia (HL-60) cells.
Yedjou CG; Rogers C; Brown E; Tchounwou PB
J Biochem Mol Toxicol; 2008; 22(2):85-92. PubMed ID: 18418892
[TBL] [Abstract][Full Text] [Related]
2. ASCORBIC ACID - MODULATION OF ARSENIC TRIOXIDE TOXICITY: IMPLICATION FOR THE CLINICAL TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA.
Yedjou CG; Brown E; Rogers C; Tchounwou PB
Met Ions Biol Med; 2008; 10():413-418. PubMed ID: 26549974
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.
Biswas S; Zhao X; Mone AP; Mo X; Vargo M; Jarjoura D; Byrd JC; Muthusamy N
Leuk Res; 2010 Jul; 34(7):925-31. PubMed ID: 20171736
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells.
Kumar S; Yedjou CG; Tchounwou PB
J Exp Clin Cancer Res; 2014 May; 33(1):42. PubMed ID: 24887205
[TBL] [Abstract][Full Text] [Related]
5. OXIDATIVE STRESS IN HUMAN LEUKEMIA (HL-60), HUMAN LIVER CARCINOMA (HepG2), AND HUMAN (JURKAT-T) CELLS EXPOSED TO ARSENIC TRIOXIDE.
Yedjou CG; Tchounwou PB
Met Ions Biol Med; 2006; 9():298-303. PubMed ID: 26435679
[TBL] [Abstract][Full Text] [Related]
6. Physiologic Doses of Ascorbic Acid Increase Arsenic Trioxide Toxicity in Human Jurkat -T Lymphoma Cells.
Yedjou CG; Byrd R; Allen L; Tchounwou PB
Met Ions Biol Med; 2011; 11():236-241. PubMed ID: 26401102
[TBL] [Abstract][Full Text] [Related]
7. High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro.
Noguera NI; Pelosi E; Angelini DF; Piredda ML; Guerrera G; Piras E; Battistini L; Massai L; Berardi A; Catalano G; Cicconi L; Castelli G; D'Angiò A; Pasquini L; Graziani G; Fioritoni G; Voso MT; Mastrangelo D; Testa U; Lo-Coco F
Oncotarget; 2017 May; 8(20):32550-32565. PubMed ID: 28427227
[TBL] [Abstract][Full Text] [Related]
8. In-vitro cytotoxic and genotoxic effects of arsenic trioxide on human leukemia (HL-60) cells using the MTT and alkaline single cell gel electrophoresis (Comet) assays.
Yedjou CG; Tchounwou PB
Mol Cell Biochem; 2007 Jul; 301(1-2):123-30. PubMed ID: 17216127
[TBL] [Abstract][Full Text] [Related]
9. BIMEL is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine.
Tanaka Y; Komatsu T; Shigemi H; Yamauchi T; Fujii Y
BMC Cancer; 2014 Jan; 14():27. PubMed ID: 24428916
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic analysis of the PI3K/Akt signaling pathway reveals the dual role of the c-Jun oncogene in cytotoxicity and the development of resistance in HL-60 leukemia cells in response to arsenic trioxide.
Roszak J; Smok-Pieniążek A; Stępnik M
Adv Clin Exp Med; 2017 Dec; 26(9):1335-1342. PubMed ID: 29442453
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
You BR; Park WH
Oncol Rep; 2012 Aug; 28(2):749-57. PubMed ID: 22684917
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism.
Doudican NA; Bowling B; Orlow SJ
Leuk Res; 2010 Feb; 34(2):229-34. PubMed ID: 19540589
[TBL] [Abstract][Full Text] [Related]
13. N-acetyl-l-cysteine affords protection against lead-induced cytotoxicity and oxidative stress in human liver carcinoma (HepG2) cells.
Yedjou CG; Tchounwou PB
Int J Environ Res Public Health; 2007 Jun; 4(2):132-7. PubMed ID: 17617676
[TBL] [Abstract][Full Text] [Related]
14. Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment.
Yedjou CG; Moore P; Tchounwou PB
Int J Environ Res Public Health; 2006 Jun; 3(2):136-40. PubMed ID: 16823087
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D3 potentiates the antitumorigenic effects of arsenic trioxide in human leukemia (HL-60) cells.
Rogers CS; Yedjou CG; Sutton DJ; Tchounwou PB
Exp Hematol Oncol; 2014 Mar; 3(1):9. PubMed ID: 24661615
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the involvement of oxidative stress and Mitogen-Activated Protein Kinase signaling pathways in the cytotoxic effects of arsenic trioxide and its combination with sulindac or its metabolites: sulindac sulfide and sulindac sulfone on human leukemic cell lines.
Stępnik M; Ferlińska M; Smok-Pieniążek A; Gradecka-Meesters D; Arkusz J; Stańczyk M
Med Oncol; 2012 Jun; 29(2):1161-72. PubMed ID: 21523454
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide suppresses transcription of hTERT through down-regulation of multiple transcription factors in HL-60 leukemia cells.
Zhang Y; Sun M; Shi W; Yang Q; Chen C; Wang Z; Zhou X
Toxicol Lett; 2015 Jan; 232(2):481-9. PubMed ID: 25436934
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells.
McCafferty-Grad J; Bahlis NJ; Krett N; Aguilar TM; Reis I; Lee KP; Boise LH
Mol Cancer Ther; 2003 Nov; 2(11):1155-64. PubMed ID: 14617789
[TBL] [Abstract][Full Text] [Related]
19. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the cellular effects and mechanism of arsenic trioxide-induced hepatotoxicity in broiler chickens.
Wang C; Ning Z; Wan F; Huang R; Chao L; Kang Z; Yang F; Zhong G; Li Y; Pan J; Tang Z; Hu L
Toxicol In Vitro; 2019 Dec; 61():104629. PubMed ID: 31442540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
